Evidence map›Paper›PMID 29344903›Full record

ReviewJournal of applied genetics2018

Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA.

Joanna Rusecka, Magdalena Kaliszewska, Ewa Bartnik, Katarzyna Tońska

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Journal of applied genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04802707 (A Phase II, Monocenter, Single Arm Study To Assess The Safety and Efficacy Of Combination Deoxycytidine and Deoxythymidine For Mitochondrial Depletion Disorders), which is not on this map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04802707 phase2recruitingnot on this mapstarted 2021, after this paper: background citation

A Phase II, Monocenter, Single Arm Study To Assess The Safety and Efficacy Of Combination Deoxycytidine and Deoxythymidine For Mitochondrial Depletion Disorders

TypeinterventionalSponsorKenneth Myers, MDRan2021 to 2029Enrolled200ConditionsMitochondrial Diseases, Mitochondrial Encephalomyopathy, Mitochondrial Encephalopathy, Mitochondrial DNA DepletionArmsdeoxycytidine and deoxythymidine
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. The role of impaired mitochondrial function in neurological manifestations of mitochondrial diseases.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Neurodegenerative Diseases in Children: A Comprehensive Review.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Leveraging mitochondrial stress to improve healthy aging.Sports medicine and health science · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Necrosis drives susceptibility toInfection and immunity · 2025
    Article
  12. Review
  13. Necrosis drives susceptibility tobioRxiv : the preprint server for biology · 2024
    Article
  14. Review
  15. Review
  16. Discovery of novel disease-causing mutation inMolecular therapy. Nucleic acids · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joanna RuseckaInstitute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, 02-106, Warsaw, Poland.
Magdalena KaliszewskaInstitute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, 02-106, Warsaw, Poland.
Ewa BartnikInstitute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, 02-106, Warsaw, Poland.
Katarzyna TońskaInstitute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, 02-106, Warsaw, Poland. kaska@igib.uw.edu.pl.ORCID http://orcid.org/0000-0002-1793-6089
University of Warsaw · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PL

Funding

Narodowe Centrum Nauki 2014/15/B/NZ5/00434
6 · The paper itself

Abstract

Mitochondrial diseases are defined by a respiratory chain dysfunction and in most of the cases manifest as multisystem disorders with predominant expression in muscles and nerves and may be caused by mutations in mitochondrial (mtDNA) or nuclear (nDNA) genomes. Most of the proteins involved in respiratory chain function are nuclear encoded, although 13 subunits of respiratory chain complexes (together with 2 rRNAs and 22 tRNAs necessary for their translation) encoded by mtDNA are essential for cell function. nDNA encodes not only respiratory chain subunits but also all the proteins responsible for mtDNA maintenance, especially those involved in replication, as well as other proteins necessary for the transcription and copy number control of this multicopy genome. Mutations in these genes can cause secondary instability of the mitochondrial genome in the form of depletion (decreased number of mtDNA molecules in the cell), vast multiple deletions or accumulation of point mutations which in turn leads to mitochondrial diseases inherited in a Mendelian fashion. The list of genes involved in mitochondrial DNA maintenance is long, and still incomplete.

Indexed as

Cell NucleusDNA, MitochondrialElectron TransportGenome, MitochondrialGenomic InstabilityHumansMitochondrial DiseasesPoint MutationDNA, MitochondrialDepletionMitochondrial diseasesMitochondrial DNA deletionsMitochondrial DNA instabilityNuclear genes

Identifiers

PMID29344903
PMCPMC5799321
OpenAlexW2789042695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.